VentriJect Partners With HCA Healthcare UK on VO2 Max Testing

VentriJect is partnering with HCA Healthcare UK to launch a no-exercise VO2 max testing innovation, according to Med Techinsights. The partnership will bring VentriJect’s Seismofit device to HCA Healthcare UK’s reAssure health screenings.

At-rest cardiorespiratory fitness assessment

Med Techinsights reports that Seismofit estimates cardiorespiratory fitness while the individual is at rest. The device is designed to estimate VO2 max in under three minutes without exercise.

VentriJect is a Danish medical technology company, Med Techinsights said. HCA Healthcare UK is described by the publisher as one of the UK’s leading private healthcare providers. Their partnership connects the Seismofit technology with HCA Healthcare UK’s screening setting.

The reported rollout places the device across reAssure health screenings. Med Techinsights characterized the launch as a first-of-its-kind VO2 max testing innovation.

Partnership details for medical technology professionals

The announcement centers on a provider partnership and a defined use case: estimating cardiorespiratory fitness and VO2 max at rest. For medical technology sales professionals, the reported arrangement highlights how an assessment device can be incorporated into a health-screening offering.

Med Techinsights identifies Seismofit as the technology at the center of the collaboration. The publisher also reports that the assessment can be completed in under three minutes, without exercise, positioning the device around an at-rest measurement process.

The partnership joins VentriJect and HCA Healthcare UK around HCA’s reAssure health screenings. No additional rollout details were provided in the supplied report.

Key reported facts

• Partners: VentriJect and HCA Healthcare UK
• Technology: Seismofit
• Reported use: Estimating cardiorespiratory fitness and VO2 max
• Assessment condition: At rest, without exercise
• Reported assessment time: Under three minutes
• Screening setting: HCA Healthcare UK’s reAssure health screenings

Med Techinsights reported the partnership on October 27, 2026.